Diabetes News and Research

Latest Diabetes News and Research

Most clinical trials of vitamin supplements have flawed methodology

Most large, clinical trials of vitamin supplements, including some that have concluded they are of no value or even harmful, have a flawed methodology that renders them largely useless in determining the real value of these micronutrients, a new analysis suggests.

31 Dec 2013

Obesity is an expensive problem, says bariatric surgeon

As a preeminent expert in the field of obesity surgery, board-certified bariatric surgeon Michael Feiz, M.D., F.A.C.S, has personally seen the physical, emotional and financial toll that obesity takes on his patients.

31 Dec 2013

GRADE study evaluates four new medications for Type 2 diabetes

The GRADE study at the University of Alabama at Birmingham had a special visitor in November. Red suit. Black boots. White beard. Belly that shook like a bowl full of jelly. A V.I.E. (Very Important Elf) visited this national clinical trial for Type 2 diabetes.

31 Dec 2013

Fructose does not have any impact on emerging marker for risk of cardiovascular disease

Fructose, the sugar often blamed for the obesity epidemic, does not itself have any impact on an emerging marker for the risk of cardiovascular disease known as postprandial triglycerides, new research has found.

30 Dec 2013

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the Company's New Drug Application for its investigational antibiotic tedizolid phosphate (TR-701) with Priority Review. The FDA has assigned a Prescription Drug User Fee Act action date of June 20, 2014. Cubist is seeking FDA approval of tedizolid for the treatment of acute bacterial skin and skin structure infections.

30 Dec 2013

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Veloxis Pharmaceuticals A/S, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Envarsus (formerly LCP-Tacro) for the prevention of organ rejection in kidney transplant recipients.

30 Dec 2013

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

Genzyme, a Sanofi company, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.

30 Dec 2013

AACE releases first 2013 list of most frequently searched endocrine medical conditions

The American Association of Clinical Endocrinologists (AACE) today released its first annual list of the most frequently searched endocrine medical conditions for 2013, as measured by visits to the organization's patient education website, www.empoweryourhealth.org.

28 Dec 2013

Support from lactation consultant improves chances of breastfeeding

In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at least for a few months-long enough for mother and child to gain health benefits. The results of the trials were published online today in American Journal of Public Health.

28 Dec 2013

Takeda terminates development activities for fasiglifam (TAK-875)

Takeda Pharmaceutical Company Limited (Takeda) announced today that it has decided voluntarily to terminate the development activities for fasiglifam (TAK-875), an investigational treatment for type 2 diabetes, due to concerns about liver safety.

27 Dec 2013

A valuable guide for diabetic patients

McCord Research, Inc., founded by Darlene McCord, Ph.D., FAPWCA, has produced a valuable guide to help people with diabetes take care of their feet for a lifetime. Dr. McCord has over 30 years of experience in the skin and wound care industry. Ten years ago she also created the most successful skin and wound care product line in North America.

27 Dec 2013

Scientists analyze nutrition and physical activity behavior that could prevent risk of diabetes

"I'm going to do more sport in the new year." Hardly any resolution is made more frequently than this one after the calorie-filled Christmas holidays - and hardly one that is broken as frequently. A team headed by Prof. Wolfgang Schlicht from the Institute for Sport and Movement Science at the University of Stuttgart are investigating behaviour techniques in the framework of the project "PREVIEW" with which the physical activity behaviour can be changed in the long term. T

27 Dec 2013

THRIL could be novel biomarker for immune activation, potential target for inflammatory diseases

Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells-macrophages-are stimulated in response to pathogens.

27 Dec 2013

Dietitians identify 14 diet, nutrition and food trends to shape Americans' waistlines in 2014

The annual nutrition expert trends forecast is in – what fad diets are hot? What's out? Which foods top the list? What are consumers eating? According to a survey of more than 500 Registered Dietitians conducted by the nutrition trade magazine, Today's Dietitian, and a leading food, health and wellness public relations agency, Pollock Communications, America's demand for nutrition information is at an all-time high and there's no shortage of outlets talking about diets.

27 Dec 2013

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering.

26 Dec 2013

Researchers uncover new genetic clue that contributes to increased risk of type 2 diabetes

An international team of researchers in Mexico and the United States has uncovered a new genetic clue that contributes to an increased risk of developing type 2 diabetes, particularly the elevated risk among Mexican and other Latin American populations.

26 Dec 2013

CAC screening plays more prominent role in determining risk for heart attack and stroke

A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person’s risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.

26 Dec 2013

Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA.

25 Dec 2013

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

Veloxis Pharmaceuticals A/S, today announced that Envarsus was granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prophylaxis of organ rejection in patients receiving allogenic kidney transplants.

24 Dec 2013

Transplanting self-donated Schwann cells aids hind limb functional recovery

A study carried out at the University of Miami Miller School of Medicine for "The Miami Project to Cure Paralysis" has found that transplanting self-donated Schwann cells (SCs, the principal ensheathing cells of the nervous system) that are elongated so as to bridge scar tissue in the injured spinal cord, aids hind limb functional recovery in rats modeled with spinal cord injury.

24 Dec 2013

Diabetes News and Research

Latest Diabetes News and Research

Most clinical trials of vitamin supplements have flawed methodology

Obesity is an expensive problem, says bariatric surgeon

GRADE study evaluates four new medications for Type 2 diabetes

Fructose does not have any impact on emerging marker for risk of cardiovascular disease

FDA accepts Cubist Pharmaceuticals' tedizolid phosphate NDA with Priority Review

Veloxis Pharmaceuticals seeks FDA approval to market Envarsus for prevention of organ rejection

Genzyme gets FDA Complete Response Letter for Lemtrada sBLA

AACE releases first 2013 list of most frequently searched endocrine medical conditions

Support from lactation consultant improves chances of breastfeeding

Takeda terminates development activities for fasiglifam (TAK-875)

A valuable guide for diabetic patients

Scientists analyze nutrition and physical activity behavior that could prevent risk of diabetes

THRIL could be novel biomarker for immune activation, potential target for inflammatory diseases

Dietitians identify 14 diet, nutrition and food trends to shape Americans' waistlines in 2014

Oramed Pharmaceuticals to purchase $15,800,000 shares in registered direct offering

Researchers uncover new genetic clue that contributes to increased risk of type 2 diabetes

CAC screening plays more prominent role in determining risk for heart attack and stroke

Antidepressant nortriptyline does not improve overall symptoms in patients with idiopathic gastroparesis

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

Transplanting self-donated Schwann cells aids hind limb functional recovery

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Diabetes News and Research

Latest Diabetes News and Research

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in